HPGC Renmintongtai Pharmaceutical Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000G05
CNY
13.29
4.88 (58.03%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
10,015.15
10,359.55
9,612.09
9,289.20
7,980.66
8,328.67
7,031.61
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
10,015.15
10,359.55
9,612.09
9,289.20
7,980.66
8,328.67
7,031.61
Raw Material Cost
9,235.72
9,450.06
8,783.48
8,376.64
7,109.08
7,355.56
6,172.55
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
35.76
36.34
54.06
56.04
35.84
29.03
27.17
Selling and Distribution Expenses
479.50
497.72
444.78
507.98
627.12
590.72
490.82
Other Expenses
-3.58
-3.63
-5.41
-5.60
-3.58
-2.90
-2.72
Total Expenditure (Excl Depreciation)
9,715.22
9,947.78
9,228.26
8,884.62
7,736.20
7,946.28
6,663.37
Operating Profit (PBDIT) excl Other Income
299.9
411.8
383.8
404.6
244.5
382.40000000000003
368.2
Other Income
13.03
18.69
15.91
12.04
12.59
8.47
10.50
Operating Profit (PBDIT)
375.78
492.99
465.77
479.31
287.19
422.11
410.01
Interest
35.76
36.34
54.06
56.04
35.84
29.03
27.17
Exceptional Items
11.75
-0.81
-0.25
-1.92
-1.74
-0.72
-5.86
Gross Profit (PBDT)
779.43
909.49
828.62
912.56
871.59
973.12
859.06
Depreciation
62.72
62.46
65.89
62.74
29.92
31.10
31.26
Profit Before Tax
289.06
393.39
345.56
358.60
219.70
361.27
345.71
Tax
75.79
101.14
81.04
82.09
74.74
93.97
87.86
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
213.27
292.16
264.48
277.30
145.26
267.33
257.86
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
213.27
292.16
264.48
277.30
145.26
267.33
257.86
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.00
0.09
0.03
-0.78
-0.31
-0.03
-0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
213.27
292.25
264.51
276.51
144.96
267.30
257.85
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,881.19
2,751.42
2,459.26
2,200.25
1,992.54
1,847.28
1,579.94
Earnings per share (EPS)
0.37
0.5
0.46
0.48
0.25
0.46
0.44
Diluted Earnings per share
0.37
0.5
0.46
0.48
0.25
0.46
0.44
Operating Profit Margin (Excl OI)
3.0%
3.98%
3.99%
4.35%
3.07%
4.59%
5.24%
Gross Profit Margin
3.51%
4.4%
4.28%
4.54%
3.13%
4.71%
5.36%
PAT Margin
2.13%
2.82%
2.75%
2.99%
1.82%
3.21%
3.67%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -3.32% vs 7.78% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -27.00% vs 10.47% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -23.53% vs 5.42% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -1.38% vs -32.90% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of HPGC Renmintongtai Pharmaceutical Corp. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
10,015.15
0
10,015.15
Other Operating Income
0.00
0.00
0.00
Total Operating income
10,015.15
0
10,015.15
Raw Material Cost
9,235.72
0
9,235.72
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
35.76
0
35.76
Selling and Distribution Expenses
479.50
0
479.50
Other Expenses
-3.58
0.00
-3.58
Total Expenditure (Excl Depreciation)
9,715.22
0
9,715.22
Operating Profit (PBDIT) excl Other Income
299.93
0.00
299.93
Other Income
13.03
0
13.03
Operating Profit (PBDIT)
375.78
0
375.78
Interest
35.76
0
35.76
Exceptional Items
11.75
0
11.75
Gross Profit (PBDT)
779.43
0
779.43
Depreciation
62.72
0
62.72
Profit Before Tax
289.06
0
289.06
Tax
75.79
0
75.79
Provisions and contingencies
0
0
0.00
Profit After Tax
213.27
0
213.27
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
213.27
0
213.27
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.00
0
-0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
213.27
0
213.27
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,881.19
0
2,881.19
Earnings per share (EPS)
0.37
0
0.37
Diluted Earnings per share
0.37
0
0.37
Operating Profit Margin (Excl OI)
3.00%
0%
0.00
3.00%
Gross Profit Margin
3.51%
0%
0.00
3.51%
PAT Margin
2.13%
0%
0.00
2.13%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 1,001.52 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -3.32% vs 7.78% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 21.33 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -27.00% vs 10.47% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 36.27 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -23.53% vs 5.42% in Dec 2023

Annual - Interest
Interest 3.58 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -1.38% vs -32.90% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.00%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023